Sri Lanka gears up to send its workers abroad as virus threat eases

People wearing facemasks outside a shop in Colombo, Sri Lanka. (Shutterstock)
Short Url
Updated 01 June 2020

Sri Lanka gears up to send its workers abroad as virus threat eases

  • Billions in remittances affected by outbreak

COLOMBO: Sri Lanka will soon begin sending its workers back overseas as it further eases its COVID-19 measures and host countries start reopening their borders.

The estimated number of overseas Sri Lankan workers is 1.5 million and 1.2 million of these are in the Middle East, according to an official from the Bureau of Foreign Employment (SLBFE).

“The island had halted the process on March 13 due to the COVID-19 outbreak,” the bureau’s acting general manager, W.M.V Wansekera, told Arab News. “We will soon prepare to send them abroad with the opening of airports in the host countries.”

He hoped that the country would soon return to normality and once again be able to export its workforce, which is responsible for an estimated $7 billion in remittances every year.

The majority of the 1.2 million Sri Lankan workers in the Middle East - 80 percent - are stationed in Gulf countries such as Saudi Arabia, the UAE, Kuwait, and Qatar.

On May 26 the bureau sent a batch of 145 workers to Hong Kong – far lower than the 15,000 Lankan workers sent abroad on average every month – after they were stranded in the country during their annual vacation due to the lockdown, Jagath Batugedera, the bureau’s assistant general manager, told Arab News.

The director general of health services, Dr. Anil Jasinghe, said that his ministry had been able to keep the disease under control from April 30 and that zero cases had been recorded in the civilian population.

There were a few cases of infection in the Sri Lankan navy and 450 new cases among workers who had come back from Kuwait. As of Sunday a total of 1,620 diagnosed cases were reported, with 801 recoveries and 10 deaths.

Foreign Secretary Ravinatha Ariyasingha told Arab News that more than 38,983 workers in 143 countries had expressed an interest to return home to Sri Lanka, based on information gathered through the “Contact Sri Lanka” web portal from the Ministry of Foreign Relations.

Expatriates who spoke to Arab News said they were happy to be overseas. Mohammed Ali, an accountant working at a private firm in Riyadh, said Sri Lankan workers were “satisfied” with the new conditions laid out by the Kingdom.

“We have been staying here during good times, and we also like to stay in these trying times too,” he told Arab News. He added that, while there had been a 25 percent reduction in salary, workers were advised to only work six hours. He called this an “acceptable move” and said another “good thing” was that there had been no retrenchment of workers due to the coronavirus crisis.

Expatriate Mohammed Risqi, who holds an executive position in a Kuwaiti establishment, said that people wished to continue with their jobs during the global crisis.

“Those who are staying here illegally or have lost their regular jobs are keen to go home because staying in Kuwait is a waste of time,” he told Arab News.

India’s medical body accused of ‘fixing’ vaccine trial date

Updated 06 July 2020

India’s medical body accused of ‘fixing’ vaccine trial date

  • Experts say move is part of efforts to showcase progress in handling outbreak

NEW DELHI: A day after India’s apex medical body issued a clarification for setting Aug. 15 as the deadline to fast-track the trials of a vaccine for the coronavirus disease (COVID-19), doctors and health experts said on Sunday that the Indian Council of Medical Research (ICMR) was “fixing the date” for the use of the coveted drug.

“It is no coincidence that this vaccine fixing trial by the ICMR comes soon after the flabbergasting claim made by Baba Ramdev (a yoga guru) of discovering the Ayurvedic cure for COVID-19,” Harjit Singh Bhatti of New Delhi-based Progressive Medicos and Scientific Forum told Arab News.

He added that the fact the order was issued to launch the vaccine for public use by Aug. 15 implied that the results had already been given. 

“The so-called trial is only an attempt to put a veneer of validity on them,” he said.

This follows the ICMR’s directive on Tuesday asking select medical institutions to expedite the clinical trial approvals for Covaxin, a potential anti-virus candidate developed in collaboration with Bharat Biotech International, a leading vaccine and bio-therapeutics manufacturer based in Hyderabad.

“In light of the public health emergency ... and urgency to launch the vaccine, you are strictly advised to fast-track all approvals related to the initiation of the clinical trial ... no later than July 7. It is envisaged to launch the vaccine for public health use latest by Aug. 15 after completion of all clinical trials,” Dr. Balram Bhargava, ICMR director-general, wrote in the order.

The ICMR chief warned hospitals not to delay the trials, adding that “non-compliance” would be taken “very seriously.”

Faced with growing outrage over the message, the ICMR issued a statement on Saturday that claimed the six-week deadline was “to cut red tape.”

“The letter by the ICMR director-general to investigators of the clinical trial sites was meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants,” the statement said.

Health experts, however, said it was a “disturbing” development.

“It is very disturbing that the ICMR would fix a date for releasing a vaccine even before the Phase-1 trial has started. Everybody knows India mismanaged the epidemic. You cannot save face with this kind of approach to the vaccine,” Dr T. Jacob John, a biologist at the Vellore-based Christian Medical College in Tamil Nadu, told Arab News.

The missive has prompted a huge outcry among medical and political circles.

“Any doctor or scientist who has been trained to practice medicine with a scientific temperament in the service of our people would be outraged by the criminal audacity of the government,” Bhatti said.

He added that if “science were to have its way,” the trials would have been done in phases to ensure the vaccine was safe. 

Dr. Amar Jesani, Mumbai-based independent researcher and editor of the Indian Journal of Medical Ethics, said the idea was “laughable” and that it violated the ICMR’s guidelines on ethical medical practices.

“It’s a pipe dream, and you cannot have a vaccine by commanding that the vaccine should work,” Jesani told Arab News.

Meanwhile, Soumya Swaminathan, chief scientist of the World Health Organization (WHO), warned that the vaccine should not come at “the cost of scientific and ethical standards.”

“The WHO recommends that Phase-3 trials, often considered the most important, should involve up to 20-30,000 people,” she said in an interview with Indian newspapers on Sunday.

As the chief medical body of the Indian government, the ICMR is tasked with formulating guidelines to deal with COVID-19 cases in the country. 

To this end, it sets the parameters for ethical standards in medical trials, while its head reports directly to the Prime Minister’s Office.

Following the developments on Saturday, questions are now being raised as to whether the ICMR was under political pressure.

Sitaram Yechury, leader of the Communist Party of India (Marxist), said scientists were being “forced” to show results so that Prime Minister Narendra Modi could announce them during his Independence Day speech on August 15. 

“Forcing the development of an indigenous vaccine as a cure for COVID-19 by bypassing all health and safety norms... is fraught with horrendous human costs,” he tweeted on Saturday.

Jesani reasons this is owing to a “direct relationship of power with the ICMR.”

“There is no doubt that the director-general of the ICMR was assigned to get going by August 15 so that there would be something positive for the PM to say in his address to the nation. He thinks that the vaccine is the best thing to talk about,” Jesani said, adding that it could also be a means for the ICMR to redeem itself.

“No doubt the ICMR has been under great pressure for the last three months and wants to redeem its credibility…[but] it is science that ultimately controls the outcome,” he said.

As of Sunday, India had over 700,000 active COVID-19 cases with more than 20,000 deaths reported.